Examples of using Dexdomitor in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
What is DEXDOMITOR?
DEXDOMITOR 0.1 mg/ml solution for injection.
How does Dexdomitor work?
Other information about DEXDOMITOR.
What is DEXDOMITOR used for?
What is the risk associated with DEXDOMITOR?
What benefit has DEXDOMITOR shown during the studies?
Dexdomitor causes a decrease in heart rate and body temperature.
In dogs, both intravenous and intramuscular injections of DEXDOMITOR were studied.
In dogs, Dexdomitor is given by intravenous or intramuscular injection.
For a full list of all side effects reported with Dexdomitor, see the package leaflet.
Dexdomitor is used to sedate(calm down) dogs and cats in the following situations.
The dose volumeof atipamezole at the concentration of 5 mg/ml equals one-half the volume of Dexdomitor that was given to the cat.
Dexdomitor is compatible with butorphanol and ketamine in the same syringe at least for two hours.
The CVMP concluded that the benefits of Dexdomitor exceed the risks and recommended that it be given a marketing authorisation.
Dexdomitor contains dexmedetomidine as the active substance, which produces sedation and analgesia in dogs and cats.
The dose volume of atipamezole at the concentration of 5 mg/ml equals one tenth(1/10)the volume of Dexdomitor 0.1 mg/ml that was given to the cat.
In dogs, DEXDOMITOR is given by intravenous(into a vein) or intramuscular(into a muscle) injection.
No additional studies were needed as Sedadex is a generic medicine that is given by injection, is similarin composition to, and contains the same active substance as, the reference medicine, Dexdomitor.
DEXDOMITOR was at least as effective as medetomidine in inducing general anaesthesia in cats in combination with ketamine.
Dexdomitor was investigated in studies involving dogs and cats in which its effectiveness was compared with that of medetomidine.
DEXDOMITOR contains the active substance dexmedetomidine, which belongs to a class of medicines having a psycholeptic(sedative) action.
If DEXDOMITOR is accidentally self-injected or taken by mouth, seek medical advice immediately and show the Package Leaflet or the label to the doctor.
If Dexdomitor is accidentally self-injected or taken by mouth, medical advice should be sought immediately and the package leaflet or the label shown to the doctor.
DEXDOMITOR was also compared with medetomidine as a premedication in cats about to undergo general anaesthesia with ketamine and for deep sedation of dogs in combination with butorphanol.
Dexdomitor is an α 2-adrenoreceptor agonist, symptoms after absorption may involve clinical effects including dose-dependent sedation, respiratory depression, bradycardia, hypotension, a dry mouth, and hyperglycaemia.
Dexdomitor was also compared with medetomidne for premedication(sedation prior to anaesthesia) in cats about to undergo general anaesthesia with ketamine and for deep sedation of dogs in combination with butorphanol.
DEXDOMITOR also showed adequate effectiveness for deep sedation of dogs in combination with butorphanol, and as a premedication before induction of general anaesthetic, reducing the amount of anaesthetic that the dogs needed.
Dexdomitor also showed adequate effectiveness for deep sedation of dogs in combination with butorphanol, and for premedication in dogs and cats before induction of general anaesthesia, reducing the amount of anaesthetic that the dogs and cats require.